11 Results for "

dipeptidyl peptidase II

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "dipeptidyl peptidase II" in MCE Product Catalog:

37
37 Cited Publications
Cat. No.: HY-15695
CAS No.: 58-60-6
Purity:  99.86%
Synonyms: NSC 3056
Puromycin aminonucleoside (NSC 3056) is the aminonucleoside portion of the antibiotic puromycin, and used in nephrosis animal models . Puromycin aminonucleoside induces apoptosis . Puromycin aminonucleoside is a reversible inhibitor of dipeptidyl peptidase II and cytosol alanyl aminopeptidase . Puromycin aminonucleoside induces secretion of cell migrasome .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101769
CAS No.: 697797-51-6
Purity:  99.49%
Target:  

Dipeptidyl Peptidase

Research Areas:  

Cancer

UAMC00039 dihydrochloride is a potent, reversible and competitive dipeptidyl peptidase II inhibitor with an IC50 of 0.48 nM.
loading...
    loading...
Cat. No.: HY-P4468
CAS No.: 115846-24-7
Target:  

Dipeptidyl Peptidase

Research Areas:  

Others

Lys-Ala-pNA is hydrolytic substrate the of dipeptidyl peptidase (DPP) II with Km of 0.42 mM .
loading...
    loading...
Cat. No.: HY-151578
CAS No.: 2836996-95-1
DPP IV/hCA II-IN-1 is a potent and selective dipeptidyl peptidase IV (DPP IV) and carbonic anhydrase (CA) inhibitor with an IC50 value of 0.049 μM for DPP IV and with Ki values of 0.0361, 0.0428, 0.0941, 0.1328, 0.2615, and 3.034 μM for CA II, CA VB, CA VA, CA IX, CA I, and CA IV, respectively .
loading...
    loading...
Cat. No.: HY-15695R
CAS No.: 58-60-6
Synonyms: NSC 3056 (Standard)
Puromycin aminonucleoside (Standard) is the analytical standard of Puromycin aminonucleoside. This product is intended for research and analytical applications. Puromycin aminonucleoside (NSC 3056) is the aminonucleoside portion of the antibiotic puromycin, and used in nephrosis animal models[1]. Puromycin aminonucleoside induces apoptosis[2]. Puromycin aminonucleoside is a reversible inhibitor of dipeptidyl peptidase II and cytosol alanyl aminopeptidase[3]. Puromycin aminonucleoside induces secretion of cell migrasome[4].
loading...
    loading...
Cat. No.: HY-182374
CAS No.: 928161-33-5
Research Areas:  

Cancer

AX8819 is a selective dipeptidyl peptidase II (DPP II) inhibitor with an IC50 of 0.88 nM. AX8819 induces caspase-dependent apoptosis. AX8819 exhibits low non-specific toxicity toward proliferating T cells. AX8819 can be used for the research of B cell chronic lymphocytic leukemia .
loading...
    loading...
Cat. No.: HY-P75280
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: DPP7; DPP II; dipeptidyl peptidase 7; QPP; DPP2; dipeptidyl Arylamidase II; Quiescent Cell Proline Dipeptidase; dipeptidyl-peptidase II; dipeptidyl Aminopeptidase II; dipeptidylpeptidase 7; dipeptidyl peptidase 2; Carboxytripeptidase; DPPII; DPP; Dipeptid
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P75712
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: DPP7; DPP II; dipeptidyl peptidase 7; QPP; DPP2; dipeptidyl Arylamidase II; Quiescent Cell Proline Dipeptidase; dipeptidyl-peptidase II; dipeptidyl Aminopeptidase II; dipeptidylpeptidase 7; dipeptidyl peptidase 2; Carboxytripeptidase; DPPII; DPP; Dipeptid
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P81084
Synonyms: Angiotensin Converting Enzyme 1; ACE; ACE-T; Angiotensin-converting enzyme isoform 1precursor; dipeptidyl carboxy peptidase 1; Kininase II; ACE-1; testis-specific isoform precursor. ACE 1; ACE T; ACE1; Angiotensin converting enzyme somatic isoform; Angiotensin converting enzyme testis specific isoform; Angiotensin I converting enzyme; Angiotensin I converting enzyme 1; Angiotensin I converting enzyme peptidyl dipeptidase A 1; Carboxycathepsin; CD 143; CD143; CD143 antigen; DCP 1; DCP; DCP1; dipeptidyl carboxypeptidase 1; MVCD3; peptidase P; Peptidyl dipeptidase A; Testicular ECA; ACE_HUMAN.

Host:  

Rabbit

Application:  

WB, IHC-P, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P85520
Synonyms: ACE 1; ACE; ACE T; ACE_HUMAN; ACE1; Angiotensin converting enzyme somatic isoform; Angiotensin converting enzyme testis specific isoform; Angiotensin I converting enzyme; Angiotensin I converting enzyme 1; Angiotensin I converting enzyme peptidyl dipeptidase A 1; Angiotensin-converting enzyme; Carboxycathepsin; CD 143; CD143; CD143 antigen; DCP 1; DCP; DCP1; dipeptidyl carboxypeptidase 1; dipeptidyl carboxypeptidase I; Kininase II; MGC26566; MVCD3; peptidase P; Peptidyl dipeptidase A; soluble form; Testicular ECA.

Host:  

Mouse

Application:  

WB

Reactivity:  

Mouse

loading...
    loading...
Cat. No.: HY-L040
1,172 compounds

Diabetes mellitus, usually called diabetes, is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. The most common types are Type I and Type II. Type I diabetes (T1D), also called juvenile onset diabetes mellitus or insulin-dependent diabetes mellitus, is characterized by destruction of the β-cells of the pancreas and insulin is not produced, whereas type II diabetes (T2D), also called non-insulin-dependent diabetes mellitus, is characterized by a progressive impairment of insulin secretion and relative decreased sensitivity of target tissues to the action of this hormone. Type 2 diabetes accounts for the vast majority of all diabetes mellitus. Diabetes of all types can lead to complications in many parts of the body and can increase the overall risk of dying prematurely. Possible complications include kidney failure, leg amputation, vision loss and nerve damage.

The pathogenesis of diabetes is complicated, and development of the safe and effective drugs against diabetes is full of challenge. Increasing studies have confirmed that the pathogenesis of diabetes is related to various signaling pathways, such as insulin signaling pathway, AMPK pathway, PPAR regulation and chromatin modification pathways. These signaling pathways have thus become the major source of the promising novel drug targets to treat metabolic diseases and diabetes.

MCE Anti-diabetic Compound Library owns a unique collection of 1,172 compounds, which mainly target SGLT, PPAR, DPP-4, AMPK, Dipeptidyl Peptidase, Glucagon Receptor, etc. This library is a useful tool for discovery anti-diabetes drugs.

  • 1